These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 11790166)
1. Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: the severity-weighted assessment tool (SWAT). Stevens SR; Ke MS; Parry EJ; Mark J; Cooper KD Arch Dermatol; 2002 Jan; 138(1):42-8. PubMed ID: 11790166 [TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now? Scarisbrick JJ; Kim YH; Whittaker SJ; Wood GS; Vermeer MH; Prince HM; Quaglino P Br J Dermatol; 2014 Jun; 170(6):1226-36. PubMed ID: 24641480 [TBL] [Abstract][Full Text] [Related]
4. Leonine facies (LF) and mycosis fungoides (MF): A single-center study and systematic review of the literature. Brown DN; Wieser I; Wang C; Dabaja BS; Duvic M J Am Acad Dermatol; 2015 Dec; 73(6):976-86. PubMed ID: 26476898 [TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
6. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement. Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999 [TBL] [Abstract][Full Text] [Related]
7. How big is your hand and should you use it to score skin in cutaneous T-cell lymphoma? Scarisbrick JJ; Morris S Br J Dermatol; 2013 Aug; 169(2):260-5. PubMed ID: 23621659 [TBL] [Abstract][Full Text] [Related]
8. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. van Doorn R; Van Haselen CW; van Voorst Vader PC; Geerts ML; Heule F; de Rie M; Steijlen PM; Dekker SK; van Vloten WA; Willemze R Arch Dermatol; 2000 Apr; 136(4):504-10. PubMed ID: 10768649 [TBL] [Abstract][Full Text] [Related]
9. Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications. Kern DE; Kidd PG; Moe R; Hanke D; Olerud JE Arch Dermatol; 1998 Feb; 134(2):158-64. PubMed ID: 9487207 [TBL] [Abstract][Full Text] [Related]
10. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis. Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308 [TBL] [Abstract][Full Text] [Related]
11. Total body-surface area as a new prognostic variable in mycosis fungoides and Sézary syndrome. Novelli S; García-Muret P; Mozos A; Sierra J; Briones J Leuk Lymphoma; 2016 May; 57(5):1060-6. PubMed ID: 27096891 [TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides--a review of the management of 28 patients and of the recent literature. Lenane P; Powell FC; O'Keane C; Dervan P; O'Sullivan D; Bourke E; O'Loughlin S Int J Dermatol; 2007 Jan; 46(1):19-26. PubMed ID: 17214715 [TBL] [Abstract][Full Text] [Related]
13. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic. Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous T-cell lymphoma first presenting at the tumor stage. A clinicopathologic study. Schewach-Millet M; Azizi E; Semah D; Bubis JJ; Chaitchuk S Int J Dermatol; 1984 May; 23(4):275-8. PubMed ID: 6735555 [TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Kim YH; Chow S; Varghese A; Hoppe RT Arch Dermatol; 1999 Jan; 135(1):26-32. PubMed ID: 9923777 [TBL] [Abstract][Full Text] [Related]
16. Uncommon presentation of mycosis fungoides: eyelid margin involvement. Gül U; Soylu S; Aslan E; Yazar Z; Demiriz M J Dermatol; 2008 Sep; 35(9):581-4. PubMed ID: 18837703 [TBL] [Abstract][Full Text] [Related]
17. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome. Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705 [TBL] [Abstract][Full Text] [Related]
18. Perspectives on cutaneous T cell lymphoma. Clendenning WE Clin Exp Dermatol; 1986 Mar; 11(2):109-26. PubMed ID: 3013469 [No Abstract] [Full Text] [Related]
19. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome. Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336 [TBL] [Abstract][Full Text] [Related]
20. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]